International Clinical Trial: Efficacy of Lactobacillus Rhamnosus GG add-on therapy in mild-to-moderate ulcerative colitis

Geneva, April 20 -- International Clinical Trials Registry received information related to the study (ISRCTN12207718) titled 'Efficacy of Lactobacillus Rhamnosus GG add-on therapy in mild-to-moderate ulcerative colitis' on April 8.

Study Type: Interventional

Study Design: Allocation: Randomized controlled trial Masking: Blinded (masking used) Control: Placebo Assignment: Parallel Purpose: Treatment

Primary Sponsor: Dicofarm S.p.A.

Condition: Ulcerative colitis Digestive System

Intervention: At the screening visit (Week -2), patients will sign the informed consent and will be assessed according to the inclusion and exclusion criteria. Blood tests and fecal calprotectin measurements will be performed. Participants are randomised in...